Fundraising FoxMagnolia Neurosciences
New York, US · Founded 2018 · Delaware corporation · 6 known investors
Find your way into Magnolia Neurosciences
Sign up to find every way you can get introduced to Magnolia Neurosciences
- Your email: who you already know at Magnolia Neurosciences, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Magnolia Neurosciences team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
MJ
M. Johnston ErwinNamed on SEC filing
IH
Ian HowesNamed on SEC filing
TL
DS
David SchubertNamed on SEC filing
KM
Kendall MohlerNamed on SEC filing
Board
BD
Barbara DaltonBoard director
JM
Joel MarcusBoard director
SG
Steve GillisBoard director
AX
Asish XavierBoard director
MC
Investors · 6
Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M
How we know: Pfizer Venture Investments's portfolio page · Not right? Tell us
180 Degree CapitalreportedMenlo Park
How we know: press coverage · Not right? Tell us
AbbViereportedCambridge · $300K – $3M
How we know: press coverage · Not right? Tell us
ACCELERATOR LIFE SCIENCE PARTNERSreportedSeattle
How we know: funding news · press coverage · Not right? Tell us
AlexandriareportedPasadena
How we know: press coverage · Not right? Tell us
ARCH Venture PartnersreportedChicago · $50K – $250M
How we know: press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$26.4M disclosed across 2 rounds · 2018–2020
▶$18.4MraisedNov 2021 · 9 investors · BiotechnologyRule 506(b)
▶$18.4MraisedNov 2021 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thong LeExecutive Officer, Director
- Steve GillisDirector
- Alice LyDirector
- Kendall MohlerExecutive Officer
- Michael BaranDirector
- Ian HowesExecutive Officer
- Offering amount
- $18.4M
- Amount sold
- $18.4M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$8MraisedAug 2018 · 11 investors · BiotechnologyRule 506(b)
▶$8MraisedAug 2018 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Barbara DaltonDirector
- M. Johnston ErwinDirector
- Ian HowesExecutive Officer
- Joel MarcusDirector
- Thong LeExecutive Officer, Director
- David SchubertExecutive Officer
- Steve GillisDirector
- Kendall MohlerExecutive Officer
- Asish XavierDirector
- Margarita ChavezDirector
- Offering amount
- $13.1M
- Amount sold
- $8M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Magnolia Neurosciences's investors?
- Magnolia Neurosciences's investors include Pfizer Venture Investments, 180 Degree Capital, AbbVie, ACCELERATOR LIFE SCIENCE PARTNERS, Alexandria, ARCH Venture Partners.
- How much funding has Magnolia Neurosciences raised?
- Magnolia Neurosciences has disclosed $26.4M raised across 2 rounds.
- Where is Magnolia Neurosciences headquartered?
- Magnolia Neurosciences is headquartered in New York, US.